A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Canagliflozin in Older Children and Adolescents With Type 2 Diabetes Mellitus
Clinical trial NCT02000700 · COMPLETED
Trial details
- NCT number
- NCT02000700
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-04-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.